SB 146, titled the Glucagon Amendments, expands Utah’s school health framework to specifically address diabetic emergencies in public and private primary and secondary schools. The bill allows schools to stock glucagon kits, creates a new training program for teachers and school employees who volunteer to become qualified adults, and authorizes those trained adults to administer glucagon to a student with diabetes who is showing symptoms of hypoglycemia and has the required glucagon authorization on file. It also updates related definitions and cross-references throughout the school health statutes and pharmacy statutes to incorporate glucagon alongside existing epinephrine auto-injector and stock albuterol provisions.
The bill establishes a standing prescription process so schools and qualified adults can obtain glucagon kits from pharmacists or pharmacy interns without an individual prescription, using protocols approved by the Department of Health and Human Services. It also requires counseling on storage, administration, side effects, and emergency follow-up when glucagon kits are dispensed, and directs the department to adopt rules for training and storage standards. In addition, the bill extends civil liability protections to qualified adults, prescribers, dispensers, trainers, schools, school districts, and related public health entities acting in good faith under the new glucagon provisions.
SB 146’s impact on state law is to add glucagon as a third school-emergency medication category, alongside epinephrine auto-injectors and stock albuterol, and to create a new Section 26B-4-412 governing glucagon training in schools. It amends multiple sections in Title 26B and Title 58 to align school storage, dispensing, standing orders, training, and immunity rules with the new glucagon program. The bill does not appropriate money and takes effect on July 1, 2025.
The general sentiment around the bill appears strongly favorable and noncontroversial. It passed the Senate committee, Senate second reading, Senate third reading, House committee, and House third reading unanimously or near-unanimously, with no recorded dissenting votes. The absence of committee transcript debate suggests the bill was viewed as a practical school health measure rather than a contested policy change.
Notable points of contention are minimal in the available record. The bill preserves voluntariness for school employees, stating that schools may not require staff to become qualified adults and may not retaliate against those who decline. It also clarifies that schools are not required to stock glucagon kits and that parents or guardians remain responsible for providing a student’s medication, which may have been intended to address concerns about mandates, liability, and cost.
The bill amends Utah’s school health and pharmacy statutes to authorize schools to stock glucagon kits, create a glucagon training program for qualified adults, and permit pharmacists and pharmacy interns to dispense glucagon kits under standing prescription drug orders. It also expands immunity provisions to cover glucagon-related prescribing, dispensing, training, storage, and administration, and requires the Department of Health and Human Services to adopt rules and approve training and storage standards. These changes affect public and private primary and secondary schools, school employees, pharmacists, pharmacy interns, physicians, and local health entities.
The bill’s legislative history shows broad support and no recorded opposition. It received unanimous favorable recommendations in committee and passed both chambers with overwhelming or unanimous votes. The record suggests the measure was treated as a straightforward student safety and emergency preparedness bill, with little apparent controversy.
There is little evidence of substantive contention in the available materials. The main policy balance built into the bill is between expanding emergency access to glucagon in schools and preserving voluntariness for staff and non-mandatory stocking for schools. The bill also explicitly states that parents or guardians remain responsible for a student’s medication, which appears designed to address concerns that schools could be seen as replacing family or medical responsibility. No specific opposing arguments or dissenting legislators are identified in the provided record.